TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 38 filers reported holding TREVI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 9.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | – | 10,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $27,175,199 | 2.07% |
| Fairmount Funds Management LLC | 5,190,360 | $12,404,960 | 1.75% |
| VR Adviser, LLC | 3,422,397 | $8,179,529 | 1.31% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $16,445,805 | 0.98% |
| Opaleye Management Inc. | 1,701,500 | $4,066,585 | 0.97% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 885,924 | $2,117,358 | 0.66% |
| Rubric Capital Management LP | 5,684,420 | $13,585,764 | 0.58% |
| Tejara Capital Ltd | 180,227 | $430,743 | 0.21% |
| PFS Partners, LLC | 100,000 | $239,000 | 0.20% |
| WealthTrust Axiom LLC | 93,500 | $223,465 | 0.07% |